ALNYLAM PHARMACEUTICALS, INC.: accounts_payable
| Value | {"amount": 40572000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-09-30) |
| Status | current |
| Entity | ALNYLAM PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/371e5188-3b8b-4ac7-b4b0-6389bc65422a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001178670-22-000026Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001178670/accounts-payable/2022-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/371e5188-3b8b-4ac7-b4b0-6389bc65422a
History
- no predecessors — first report